CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER od E. N. Imyanitov, T. Yu. Semiglazova

Dokumenty pełnotekstowe

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER od N. A. Kozyavin, T. Yu. Semiglazova

Dokumenty pełnotekstowe

Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer od V. A. Kostorov, T. Yu. Semiglazova, A. V. Pavlysh

Dokumenty pełnotekstowe

DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST od T. Yu. Semiglazova, G. M. Teletaeva, N. A. Kozyavin, A. V. Zagatina

Dokumenty pełnotekstowe

The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state od T. Yu. Semiglazova, N. A. Brish, T. Yu. Galunova, A. S. Bernatskiy, V. V. Semiglazov

Dokumenty pełnotekstowe

Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors od Van Shu, A. S. Artemieva, E. A. Busco, V. V. Semiglazov, T. Yu. Semiglazova

Dokumenty pełnotekstowe

The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study) od V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev

Dokumenty pełnotekstowe

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer od T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

Dokumenty pełnotekstowe

Features of nutritional support during stem cell transplantation od S. A. Volchenkov, L. V. Filatova, E. V. Cherkasova, A. K. Koviazin, S. V. Lyubimov, I. S. Zyuzgin, T. Yu. Semiglazova

Dokumenty pełnotekstowe

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) od V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Dokumenty pełnotekstowe

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment od V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

Dokumenty pełnotekstowe

International rehabilitation model for oncological patients od T. Yu. Semiglazova, V. A. Klyuge, B. S. Kasparov, K. O. Kondratyeva, A. A. Krutov, M. A. Zernova, V. A. Chulkova, V. V. Semiglazov

Dokumenty pełnotekstowe

2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance od V. A. Alexandrov, G. V. Tochilnikov, S. V. Shatik, A. N. Stukov, O. A. Beljaeva, E. V. Bashkatova, V. G. Dranishnikov, T. Yu. Semiglazova

Dokumenty pełnotekstowe

Activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propandyоl (chlonisol) versus lomustine in intracranial transplanted tumor model in mice od Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova

Dokumenty pełnotekstowe

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma od Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova

Dokumenty pełnotekstowe

Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma od I. G. Murazov, A. N. Stukov, Iu. G. Zmitrichenko, A. O. Niuganen, G. V. Tochilnikov, D. Ch. Latipova, L. V. Filatova, T. Yu. Semiglazova

Dokumenty pełnotekstowe

Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer od R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova

Dokumenty pełnotekstowe

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction od A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko

Dokumenty pełnotekstowe

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma od E. V. Kharchenko, T. Yu. Semiglazova, A. S. Artem’yeva, G. S. Kireyeva, I. L. Polyatskin, I. S. Zyuzgin, L. V. Filatova, Yu. A. Chudinovskikh, M. S. Motalkina, Yu. A. Oleynik

Dokumenty pełnotekstowe

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... od E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

Dokumenty pełnotekstowe